Kamada Ltd. (KMDA.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
1,653.00-5.00 (-0.30%)
At close: 9:24 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1,658.00
Bid1,655.00 x 346500
Ask1,656.00 x 57900
Day's Range1,650.00 - 1,666.00
52wk Range13.03 - 1,666.00
1y Target EstN/A
Market Cap60.2B
P/E Ratio (ttm)-7,871.43
Avg Vol (3m)39,359
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Our Take On Kamada Ltd (KMDA)’s Upcoming Catalysts
    Insider Monkey19 days ago

    Our Take On Kamada Ltd (KMDA)’s Upcoming Catalysts

    So we just learnt that development stage biotech company Kamada Ltd (NASDAQ:KMDA) is set to put out topline from a phase II in antitrypsin deficiency before the end of this quarter, and intends to file a biologics licensing application (BLA) with the FDA any time now. It’s going to be a busy couple of months […]

  • Associated Press27 days ago

    Kamada reports 2Q loss

    On a per-share basis, the Ness Ziona, Israel-based company said it had a loss of 4 cents. Losses, adjusted for stock option expense, were 3 cents per share. The biopharmaceutical posted revenue of $19.1 ...

  • GlobeNewswire27 days ago

    Kamada Reports Financial Results for the Second Quarter and First Six Months of 2016

    Total Revenues for First Half of 2016 Grew 20% to $33.9 Million vs. Proprietary Products Revenue Grew 46% to $23.2 Million in First Half of 2016 vs. Company Reiterates 2016 Revenue Guidance and 2017 Sales ...